Correlates of health-related quality of life in French people with type 2 diabetes
Introduction
Type 2 diabetes (T2D) is one of the most frequent chronic diseases in adults reaching 3.2% in French people older than 18 years and 11% in those older than 65 years [1]. The burden of diabetes is known to be heavy, as it involves high rates of disability, participation restrictions and decreased life expectancy. The health burden of diabetes is associated with an increasing economic burden, particularly in the oldest [2]. Effective interventions are thus needed to decrease these negative impacts in various populations with diabetes.
Patient's perception of his/her own quality of life is considered as a valuable basis to identify targets for improvement. Health-related quality of life (HrQoL) is therefore one of the major end-points of recent clinical trials in people with diabetes [3], [4]. HrQoL assessment with the generic instrument SF-36 or its shorter version SF-12 has been used in people in T2D along with diabetes-specific instruments. The SF12 questionnaire is an instrument used to measure overall physical and mental health. Using a generic instrument allows comparisons with the general population. In France, in 2003, a previous large cross-sectional study obtained SF-36 scores in 22,743 community dwellers aged 18–84 years old including 3.4% patients with diabetes [5]. Diabetes was shown to be a predictor of lower scores in all of the 8 subscales independently of socio-economic status and diseases such as ischaemic heart disease, heart failure, cancer and hypertension. Similar results have been shown in German [6] or Korean populations [7]. However, in people with T2D and with diverse co-morbidities, the impact of diabetes on HrQoL is not easily distinguishable from that of other diseases or disabilities [8], [9]. Previous studies investigating HrQoL in populations with T2D may have been of limited power due to limited sample sizes [10], [11], [12], [13], or may have addressed only specific populations [14], [15], [16]. In a study focused on 7606 people with chronic diseases, including 14% people with diabetes, factors associated with lower HrQoL scores were not limited to the disease and its consequences but depended strongly on socio-economic factors [17]. Thus, although it has been shown that HrQol was associated with the characteristics of the diabetes disease [18], estimating the respective contribution of diverse factors on HrQol is necessary to better evaluate any intervention. For this purpose, a high power study is needed to assess the relative influences of multiple factors on HrQol.
Using the large ENTRED 2007 cross-sectional study (Échantillon national témoin représentatif des personnes diabétiques), based on a representative of adults with diabetes living in metropolitan France in 2007 [19], the aim of our analysis was to assess HrQol in people with T2D and to estimate the relative contributions of socio-demographic factors, diabetes characteristics, complications and treatment, social support and functional impairment in daily living, in mental and physical components of HrQol.
Section snippets
Population
The ENTRED 2007 study is based on a representative sample of 8926 adults with diabetes, aged 18 years and over, treated for diabetes and living in metropolitan France. This sample was randomly extracted from the database of two National Health Insurance Services: The health insurance for employers and their relatives, CNAMTS (Caisse Nationale d’Assurance Maladie, 75% of people living in France) and the health insurance of independent workers (RSI, 5% of people living in France) from all
Results
PQ were available in 48% of the sample (among those with type 2 diabetes: n = 3894 or 2282 males, 1612 females). MQ were obtained for 57% of the responders with type 2 diabetes (N = 2232). SF-12 MCS and PCS were available in 2832 patients with T2D (Fig. 1). Missing responses in the PQ led to missing SF-12 summaries in 1062 patients. Non respondents to PQ and those with missing SF12 were older than the respondents (65.4 years (SD 14.3) vs. 63.8 years (SD 10.8), p < 0.0001), and more often women (48.1%
Discussion
The factors associated with lower scores of HrQol summaries in French patients with type 2 diabetes are multiple, in relation with socio-economic conditions, social support, diabetes complications, disability and social participation restriction. The effect of current blood poor glucose control is somewhat weak and seen only for mental and not physical HrQol, and diabetes duration had no impact on HrQol after adjustment.
According to age and sex, trends for SF-12 summaries in ENTRED are similar
Scientific committee ENTRED
C. Attali, C. Avril, M. Besnier, J. Bloch, I. Bourdel-Marchasson, M. Chantry, B. Detournay, E. Eschwège, A. Fagot-Campagna, S. Fosse, A. Fontbonne, C. Fournier, A. Gautier, S. Halimi, P. Lecomte, A. Paumier, A. Penfornis, N. Poutignat, I. Romon, C. Roudier, A. Rudnichi, D. Simon, M. Varroud-Vidal, P. Vexiau, A. Weill.
Funding
The analysis of HrQol in the ENTRED study has been funded by French Institute of Health Monitoring, (Institut de veille sanitaire, InVS).
Conflict of interest
The authors declare that they have no conflict of interest.
Author contribution
I. Bourdel-Marchasson has participated in the ENTRED study questionnaire construction, has planned the HrQoL analysis and has written the paper. C. Druet is the head of the diabetes department of InVs and has contributed to the interpretation of data and to the writing of the paper. C. Helmer has monitored the statistical analysis and has contributed to the interpretation of data and to the writing of the paper. E. Eschwege, P. Lecomte and A.J. Sinclair have contributed to the interpretation of
Acknowledgements
Fundings of Entred 2007 study came from the French Institute of Health Monitoring, (Institut de veille sanitaire, InVS), The French National Health Insurance service (Caisse Nationale de l’Assurance Maladie CnamTS), the Health Insurance System for independent workers (Régime des Salariés Indépendants, RSI), the French National Institut for Prevention and Health Education (Institut national de prévention et d’éducation pour la santé, Inpes), and the French Health Authority (Haute Autorité de
References (44)
- et al.
Disability and quality of life in elderly people with diabetes
Diabetes Metab
(2007) - et al.
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment
J Clin Epidemiol
(1998) - et al.
Characteristics of undiagnosed diabetes in community-dwelling French elderly: the 3C study
Diabetes Res Clin Pract
(2007) - et al.
Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus
Diabetes Res Clin Pract
(2012) - et al.
Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS study
Diabetes Metab
(2012) - et al.
Quality of life in type 2 diabetes patients under intensive multitherapy
Diabetes Metab
(2007) - et al.
The effects of trust in physician on self-efficacy, adherence and diabetes outcomes
Soc Sci Med
(2009) - et al.
Key priorities in managing glucose control in older people with diabetes
J Nutr Health Aging
(2009) - et al.
European Diabetes Working Party for Older People 2011; Clinical Guidelines for Type 2 Diabetes Mellitus (EDWPOP): a report for the European Diabetes Working Party for Older People (EDWPOP) Revision Group on Clinical Practice Guidelines for Type 2 Diabetes Mellitus
Diabetes Metab
(2011) - et al.
Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes
J Am Med Dir Assoc
(2012)
Models of care, the European perspective
Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity
Diabetes Care
Not all roads lead to Rome – a review of quality of life measurement in adults with diabetes
Diabet Med
Worsening trends and increasing disparities in health-related quality of life: evidence from two French population-based cross-sectional surveys, 1995–2003
Qual Life Res
Health-related quality of life in subjects with and without type 2 diabetes: pooled analysis of five population-based surveys in Germany
Diabet Med
The relationship between diabetes mellitus and health-related quality of life in Korean adults: the Fourth Korea National Health and Nutrition Examination Survey (2007–2009)
Diabetes Metab J
Problems with the performance of the SF-36 among people with type 2 diabetes in general practice
Qual Life Res
Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany – a cross-sectional survey
Health Qual Life Outcomes
Health-related quality of life in type 2 diabetic patients
Ann Saudi Med
Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes
Qual Life Res
Quality of life, health status and clinical outcomes in type 2 diabetes patients
Qual Life Res
Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36
Singapore Med J
Cited by (38)
Evaluation of the quality of life of patients with diabetes mellitus treated with conventional or analogue insulins
2016, Diabetes Research and Clinical PracticeCitation Excerpt :Despite this finding, the studies mentioned above were sponsored by the pharmaceutical industry, and their authors declared conflicts of interest, which may challenge the results. A study conducted in France used the Medical Outcomes Study Short Form Health Survey 12 (MOS SF-12) instrument and showed that some of the variables associated with poor quality of life in patients with diabetes mellitus included low income, low educational level, long-term evolution of the disease, history of severe hypoglycaemia and insulin treatment [20], which it is similar to the findings of the present study and to those reported by Davis et al. in 2001 [37]. Also, the increased risk for poor quality of life found in patients older than 60 years, as was found in the study of Hervas can be due to the sum of various factors, including a higher incidence of comorbidities and polypharmacy, long-term illness, secondary complications of diabetes, lower education, poor social support [24], and even, as described in the ADVANCE study may be part of the ageing process [38].
Quality of life and mental health measurements among patients with type 2 diabetes mellitus: a systematic review
2023, Health and Quality of Life OutcomesA model of health-related quality of life during COVID-19 pandemic: the role of food customer loyalty and affordability
2023, International Journal of Quality and Reliability ManagementCost-Effectiveness of Health Literacy Enhancement Intervention on Patients with Type II Diabetes
2023, Medical Journal of the Islamic Republic of Iran